Quid Pro Quo (QPQ) Tracker
← Back to Influence Map
Entity DossierOrganization

Pfizer

One of the world's largest pharmaceutical companies ($58.5 billion revenue in 2023). Maker of the COVID-19 vaccine (Comirnaty), Paxlovid, and extensive oncology portfolio.

pharmaceuticalsinsider trading

Tracked direct giving

$1,020,000

Connections

13

Coalition view

Pfizer operates as part of a multi-committee coalition with Pfizer Inc. PAC. Combined tracked totals across all coalition members below give the figure most public sources quote (Sludge, JNS, OpenSecrets).

Combined direct giving + IE support

$2,869,780

Combined tracked receipts

$230,763

Federal Contracts and Awards

Federal obligations, FY2015–FY2025

$43.87B

Totals are complete for each fiscal year, as reported by USASpending.gov for PFIZER INC and its subsidiaries. Window matches the election cycles this tracker holds FEC data for.

Fiscal yearContract obligationsGrant obligationsOther obligationsTotal obligatedTop awarding agencies
FY2025selected$699.8M$0$0$699.8MHealth and Human Services $698.7M · Defense $1.1M
FY2024$1.34B$0$0$1.34BHealth and Human Services $1.36B · Veterans Affairs $458K · Justice $5K
FY2023$3.21B-$18K$0$3.21BDefense $1.87B · Health and Human Services $1.30B · Agency for International Development $19.7M
FY2022$18.02B$0$0$18.02BDefense $16.67B · Health and Human Services $1.35B
FY2021$14.11B$0$0$14.11BDefense $13.32B · Health and Human Services $793.6M
FY2020$1.17B$0$0$1.17BHealth and Human Services $1.17B · Veterans Affairs $28K · Defense -$689K
FY2019$1.04B-$47K$0$1.04BHealth and Human Services $1.03B · Defense $5.9M · Veterans Affairs $886K
FY2018$1.09B$0$0$1.09BHealth and Human Services $1.09B · Defense $2.4M · Veterans Affairs $578K
FY2017$1.13B$0$0$1.13BHealth and Human Services $1.13B · Defense $897K · Veterans Affairs $610K
FY2016$1.14B$0$0$1.14BHealth and Human Services $1.14B · Defense $2.5M · Justice $11K
FY2015$915.5M$0$664K$916.1MHealth and Human Services $915.1M · Defense $670K · Veterans Affairs $370K

Largest contract actions, FY2025

Showing 3 of 3 actions of $250K or more on file here ($2.4M of $699.8M obligated)

Action dateObligationAgencyAwardDescription
Feb 13, 2025$1.2MHealth and Human ServicesOffice of Assistant Secretary for Preparedness and Response75A50325F63003STERILE WATER FOR INJECTION 20ML
Aug 26, 2025$787KDefenseDefense Logistics AgencySPE2D025F06348511599130!OTHER MEDICAL
Jul 7, 2025$410KHealth and Human ServicesCenters for Disease Control and Prevention75D30122F00001mod P00009PFIZER VACCINES STORAGE AND ROTATION CONTRACT
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Donations Given and Outside Spending

Largest 50 records. Rows badged “Spent to support” or “Spent to oppose” are independent expenditures this entity paid to vendors for or against the named candidate. That money was not given to them.

RecipientAmountDateCycle
Trump Inaugural Committee (2025)$1,000,000Dec 19, 20242024
Mark Green$20,000Feb 1, 20232024

Relationships

TypeConnected ToDetailsSource
Commented onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2023-0191: Patient Protection and Affordable Care Act, Notice of Benefit and Payment Parameters for 2025; Updating Waiver Public Notice Procedures; Medicaid; ConSource
Lobbied onMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source
RetainedTHE DUBERSTEIN GROUP INC.Hired THE DUBERSTEIN GROUP INC. to lobby on NIH March-In RightsSource
RetainedMARSHALL & POPP, LLCHired MARSHALL & POPP, LLC to lobby on PharmaceuticalsSource
RetainedTHE WASHINGTON TAX & PUBLIC POLICY GROUPHired THE WASHINGTON TAX & PUBLIC POLICY GROUP to lobby on Lower Energy Costs ActSource
Funded research atThe Brookings InstitutionPfizer corporate donor to Brookings health policy programEditorial
Funded research atAmerican Enterprise InstitutePfizer corporate donor to AEI health policy researchEditorial
Coalition withPharmaceutical industryPfizer is one of the world's largest pharmaceutical companies and a key PhRMA memberEditorial
OpposedMedicare Drug Price Negotiation - First 10 Drugs SelectedPfizer opposed Medicare drug price negotiation under the Inflation Reduction Act.Source
Has as instrumentPfizer Inc. PACPfizer PAC is the political arm of Pfizer Inc.Editorial
EmployedAlbert BourlaChairman and CEO of Pfizer since 2019Editorial
Parent ofPfizer Inc. PACPfizer Inc. PAC is the federal political action committee of Pfizer Inc.Source
Stock held byMark GreenMark Green holds PFE stock (1 disclosed transactions)Source